Mark Greyson
Concepts (105)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nerve Transfer | 1 | 2023 | 14 | 0.870 |
Why?
| Upper Extremity | 2 | 2023 | 96 | 0.850 |
Why?
| Hand Injuries | 2 | 2020 | 36 | 0.840 |
Why?
| Contracture | 1 | 2020 | 24 | 0.700 |
Why?
| Cicatrix | 1 | 2020 | 58 | 0.680 |
Why?
| Skin Transplantation | 1 | 2020 | 89 | 0.680 |
Why?
| Muscle, Skeletal | 2 | 2024 | 1642 | 0.540 |
Why?
| Burns | 1 | 2020 | 289 | 0.530 |
Why?
| Surgical Flaps | 3 | 2024 | 145 | 0.410 |
Why?
| Iliac Artery | 2 | 2024 | 54 | 0.280 |
Why?
| Myocutaneous Flap | 1 | 2024 | 11 | 0.230 |
Why?
| Rectus Abdominis | 1 | 2024 | 16 | 0.230 |
Why?
| Femoral Neoplasms | 1 | 2024 | 10 | 0.230 |
Why?
| Vascularized Composite Allotransplantation | 1 | 2024 | 32 | 0.220 |
Why?
| Phantom Limb | 1 | 2023 | 5 | 0.220 |
Why?
| Fractures, Open | 1 | 2024 | 30 | 0.220 |
Why?
| Peripheral Nerves | 1 | 2023 | 67 | 0.210 |
Why?
| Perforator Flap | 1 | 2023 | 34 | 0.210 |
Why?
| Tendon Injuries | 1 | 2024 | 83 | 0.210 |
Why?
| Knee Injuries | 1 | 2024 | 99 | 0.210 |
Why?
| Sarcoma, Ewing | 1 | 2024 | 88 | 0.200 |
Why?
| Mouth Neoplasms | 1 | 2022 | 87 | 0.190 |
Why?
| Neoplasms, Second Primary | 1 | 2022 | 109 | 0.190 |
Why?
| Electromyography | 1 | 2023 | 380 | 0.190 |
Why?
| Fracture Fixation, Internal | 1 | 2024 | 222 | 0.180 |
Why?
| Anesthesia | 1 | 2022 | 131 | 0.180 |
Why?
| Esthetics | 1 | 2020 | 51 | 0.170 |
Why?
| Artificial Limbs | 1 | 2023 | 173 | 0.170 |
Why?
| Replantation | 1 | 2019 | 32 | 0.160 |
Why?
| Amputation, Traumatic | 1 | 2019 | 21 | 0.160 |
Why?
| Trigger Finger Disorder | 1 | 2018 | 6 | 0.150 |
Why?
| Head and Neck Neoplasms | 1 | 2022 | 533 | 0.140 |
Why?
| Carcinoma, Squamous Cell | 1 | 2022 | 628 | 0.140 |
Why?
| Recovery of Function | 1 | 2020 | 646 | 0.130 |
Why?
| Physical Therapy Modalities | 1 | 2018 | 293 | 0.120 |
Why?
| Treatment Outcome | 3 | 2024 | 10341 | 0.100 |
Why?
| Referral and Consultation | 1 | 2018 | 736 | 0.100 |
Why?
| Retrospective Studies | 4 | 2024 | 14675 | 0.090 |
Why?
| Dilatation, Pathologic | 1 | 2011 | 61 | 0.090 |
Why?
| Molecular Probes | 1 | 2011 | 37 | 0.090 |
Why?
| Coloring Agents | 1 | 2011 | 80 | 0.090 |
Why?
| Intercellular Junctions | 1 | 2010 | 39 | 0.080 |
Why?
| Plasminogen Activator Inhibitor 1 | 1 | 2010 | 86 | 0.080 |
Why?
| Arteries | 1 | 2011 | 269 | 0.080 |
Why?
| Humans | 9 | 2024 | 130305 | 0.080 |
Why?
| Cell Communication | 1 | 2010 | 299 | 0.070 |
Why?
| Myocytes, Smooth Muscle | 1 | 2010 | 255 | 0.070 |
Why?
| Muscle, Smooth, Vascular | 1 | 2010 | 437 | 0.070 |
Why?
| Postoperative Care | 2 | 2019 | 246 | 0.070 |
Why?
| Endothelial Cells | 1 | 2010 | 744 | 0.060 |
Why?
| Rupture | 1 | 2024 | 101 | 0.060 |
Why?
| Femur Head | 1 | 2024 | 38 | 0.060 |
Why?
| Leg Injuries | 1 | 2024 | 28 | 0.050 |
Why?
| Open Fracture Reduction | 1 | 2024 | 31 | 0.050 |
Why?
| Soft Tissue Injuries | 1 | 2024 | 37 | 0.050 |
Why?
| Free Tissue Flaps | 1 | 2024 | 49 | 0.050 |
Why?
| Models, Animal | 1 | 2024 | 373 | 0.050 |
Why?
| Hand | 1 | 2023 | 152 | 0.050 |
Why?
| Positron Emission Tomography Computed Tomography | 1 | 2022 | 83 | 0.050 |
Why?
| Time-to-Treatment | 1 | 2024 | 183 | 0.050 |
Why?
| Swine | 1 | 2024 | 744 | 0.050 |
Why?
| Range of Motion, Articular | 1 | 2024 | 387 | 0.050 |
Why?
| Bone Neoplasms | 1 | 2024 | 228 | 0.050 |
Why?
| Adolescent | 1 | 2020 | 20374 | 0.050 |
Why?
| Graft Survival | 1 | 2024 | 543 | 0.050 |
Why?
| Reoperation | 1 | 2024 | 558 | 0.050 |
Why?
| Esophagoscopy | 1 | 2022 | 198 | 0.050 |
Why?
| Male | 4 | 2024 | 63748 | 0.050 |
Why?
| Child | 1 | 2020 | 20961 | 0.040 |
Why?
| Surgical Wound Infection | 1 | 2024 | 292 | 0.040 |
Why?
| Graft Rejection | 1 | 2024 | 576 | 0.040 |
Why?
| Female | 3 | 2024 | 68842 | 0.040 |
Why?
| Neoplasm Staging | 1 | 2022 | 1294 | 0.040 |
Why?
| Microsurgery | 1 | 2019 | 69 | 0.040 |
Why?
| Anastomosis, Surgical | 1 | 2019 | 150 | 0.040 |
Why?
| Carpal Tunnel Syndrome | 1 | 2018 | 27 | 0.040 |
Why?
| Time Factors | 2 | 2024 | 6615 | 0.040 |
Why?
| Preoperative Care | 1 | 2019 | 343 | 0.030 |
Why?
| Triage | 1 | 2019 | 214 | 0.030 |
Why?
| Disability Evaluation | 1 | 2018 | 291 | 0.030 |
Why?
| Comorbidity | 1 | 2018 | 1555 | 0.030 |
Why?
| Postoperative Complications | 1 | 2024 | 2511 | 0.020 |
Why?
| Methods | 1 | 2011 | 65 | 0.020 |
Why?
| Ligation | 1 | 2011 | 87 | 0.020 |
Why?
| Animals | 3 | 2024 | 35076 | 0.020 |
Why?
| Electrophoresis, Gel, Two-Dimensional | 1 | 2010 | 96 | 0.020 |
Why?
| Arterioles | 1 | 2010 | 42 | 0.020 |
Why?
| Middle Aged | 2 | 2024 | 31322 | 0.020 |
Why?
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 136 | 0.020 |
Why?
| Coculture Techniques | 1 | 2010 | 226 | 0.020 |
Why?
| Protein Transport | 1 | 2010 | 429 | 0.020 |
Why?
| Coronary Vessels | 1 | 2010 | 254 | 0.020 |
Why?
| Calcium Signaling | 1 | 2010 | 237 | 0.020 |
Why?
| Tandem Mass Spectrometry | 1 | 2010 | 453 | 0.020 |
Why?
| Recombinant Proteins | 1 | 2010 | 1314 | 0.020 |
Why?
| Aged | 1 | 2024 | 22282 | 0.010 |
Why?
| Heart Transplantation | 1 | 2010 | 714 | 0.010 |
Why?
| Mice | 2 | 2011 | 16832 | 0.010 |
Why?
| Proteomics | 1 | 2010 | 1008 | 0.010 |
Why?
| Mice, Knockout | 1 | 2010 | 2811 | 0.010 |
Why?
| Antibodies, Monoclonal | 1 | 2010 | 1372 | 0.010 |
Why?
| Cells, Cultured | 1 | 2010 | 4106 | 0.010 |
Why?
| Adult | 1 | 2024 | 35711 | 0.010 |
Why?
| Disease Models, Animal | 1 | 2011 | 4044 | 0.010 |
Why?
| Mice, Inbred C57BL | 1 | 2010 | 5365 | 0.010 |
Why?
|
|
Greyson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|